Home > Insider Trading > Filing (0001209191-18-045747)

Filing Details

Accession Number:: 0001209191-18-045747
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-07 17:55:27
Reporting Period:: 2018-08-06

Accepted Time:: 2018-08-07 17:55:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
820081	Cambrex Corp	CBM	Pharmaceutical Preparations (2834)	222476135

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1632229	Samantha Hanley	One Meadowlands Plaza East Rutherford NJ 07073	Vp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-08-06	2,500	$16.91	2,500	No	4	M	Direct
Common Stock	Acquisiton	2018-08-06	2,500	$17.81	5,000	No	4	M	Direct
Common Stock	Acquisiton	2018-08-06	3,750	$22.50	8,750	No	4	M	Direct
Common Stock	Acquisiton	2018-08-06	12,500	$41.36	21,250	No	4	M	Direct
Common Stock	Acquisiton	2018-08-06	6,250	$40.65	27,500	No	4	M	Direct
Common Stock	Disposition	2018-08-06	19,900	$62.36	7,600	No	4	S	Direct
Common Stock	Disposition	2018-08-06	7,600	$63.38	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2018-08-06	2,500	$0.00	2,500	$16.91
Common Stock	Stock Option (right to buy)	Acquisiton	2018-08-06	2,500	$0.00	2,500	$17.81
Common Stock	Stock Option (right to buy)	Acquisiton	2018-08-06	3,750	$0.00	3,750	$22.50
Common Stock	Stock Option (right to buy)	Acquisiton	2018-08-06	12,500	$0.00	12,500	$41.36
Common Stock	Stock Option (right to buy)	Acquisiton	2018-08-06	6,250	$0.00	6,250	$40.65

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2020-10-28	No	4	M	Direct
2,500	2021-10-22	No	4	M	Direct
3,750	2022-01-28	No	4	M	Direct
12,500	2022-10-21	No	4	M	Direct
18,750	2023-10-26	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.95 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.05 to $63.68 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.
The option representing a right to purchase 10,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted
The option representing a right to purchase 10,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted
The option representing a right to purchase 15,000 shares became exercisable in four equal installments beginning January 28, 2016, which was the first anniversary of the date on which the option was granted
The option representing a right to purchase 25,000 shares became exercisable in four equal installments beginning October 21, 2016, which was the first anniversary of the date on which the option was granted
The option representing a right to purchase 25,000 shares became exercisable in four equal installments beginning October 26, 2017, which was the first anniversary of the date on which the option was granted